Your browser doesn't support javascript.
loading
GLP-1 receptor agonist attenuates tubular cell ferroptosis in diabetes via enhancing AMPK-fatty acid metabolism pathway through macropinocytosis.
Shen, Rui; Qin, Songyan; Lv, Yunhui; Liu, Dandan; Ke, Qingqing; Shi, Caifeng; Jiang, Lei; Yang, Junwei; Zhou, Yang.
Afiliación
  • Shen R; Center for Kidney Disease, The Second Affiliated Hospital of Nanjing Medical University, China.
  • Qin S; Center for Kidney Disease, The Second Affiliated Hospital of Nanjing Medical University, China.
  • Lv Y; Center for Kidney Disease, The Second Affiliated Hospital of Nanjing Medical University, China.
  • Liu D; Center for Kidney Disease, The Second Affiliated Hospital of Nanjing Medical University, China.
  • Ke Q; Center for Kidney Disease, The Second Affiliated Hospital of Nanjing Medical University, China.
  • Shi C; Center for Kidney Disease, The Second Affiliated Hospital of Nanjing Medical University, China.
  • Jiang L; Center for Kidney Disease, The Second Affiliated Hospital of Nanjing Medical University, China. Electronic address: jianglei@njmu.edu.cn.
  • Yang J; Center for Kidney Disease, The Second Affiliated Hospital of Nanjing Medical University, China. Electronic address: jwyang@njmu.edu.cn.
  • Zhou Y; Center for Kidney Disease, The Second Affiliated Hospital of Nanjing Medical University, China. Electronic address: zhouyang@njmu.edu.cn.
Biochim Biophys Acta Mol Basis Dis ; 1870(4): 167060, 2024 04.
Article en En | MEDLINE | ID: mdl-38354757
ABSTRACT
Kidney tubules are mostly responsible for pathogenesis of diabetic kidney disease. Actively reabsorption of iron, high rate of lipid metabolism and exposure to concentrated redox-active compounds constructed the three main pillars of ferroptosis in tubular cells. However, limited evidence has indicated that ferroptosis is indispensable for diabetic tubular injury. Glucagon-like peptide-1 receptor agonist (GLP-1RA) processed strong benefits on kidney outcomes in people with diabetes. Moreover, GLP-1RA may have additive effects by improving dysmetabolism besides glucose control and weight loss. Therefore, the present study aimed at exploring the benefits of exendin-4, a high affinity GLP-1RA on kidney tubular dysregulation in diabetes and the possible mechanisms involved, with focus on ferroptosis and adenosine 5'-monophosphate-activated protein kinase (AMPK)-mitochondrial lipid metabolism pathway. Our data revealed that exendin-4 treatment markedly improved kidney structure and function by reducing iron overload, oxidative stress, and ACSL4-driven lipid peroxidation taken place in diabetic kidney tubules, along with reduced GPX4 expression and GSH content. AMPK signaling was identified as the downstream target of exendin-4, and enhancement of AMPK triggered the transmit of its downstream signal to activate fatty acid oxidation in mitochondria and suppress lipid synthesis and glycolysis, and ultimately alleviated toxic lipid accumulation and ferroptosis. Further study suggested that exendin-4 was taken up by tubular cells via macropinocytosis. The protective effect of exendin-4 on tubular ferroptosis was abolished by macropinocytosis blockade. Taken together, present work demonstrated the beneficial effects of GLP-1RA treatment on kidney tubular protection in diabetes by suppressing ferroptosis through enhancing AMPK-fatty acid metabolic signaling via macropinocytosis.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus / Nefropatías Diabéticas / Ferroptosis Límite: Humans Idioma: En Revista: Biochim Biophys Acta Mol Basis Dis Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus / Nefropatías Diabéticas / Ferroptosis Límite: Humans Idioma: En Revista: Biochim Biophys Acta Mol Basis Dis Año: 2024 Tipo del documento: Article País de afiliación: China